Join our community of over half-a-million healthcare professionals aiming to improve the care of patients

Understanding HER2 testing in gynecological cancers

Prof.  Fernando A.  Soares

Prof. Fernando A. Soares

PRECISION ONCOLOGY CONNECT Non-accredited Independent Medical Education
GOTIC ICAN international cancer advocacy network Biomarker Collaborative SBP (Sociedade Brasileira de Patologia)

This educational programme is supported by an Independent Educational Grant from Daiichi Sankyo.

Understanding HER2 testing in gynecological cancers Animated Video
GOTIC ICAN international cancer advocacy network Biomarker Collaborative SBP (Sociedade Brasileira de Patologia)

This educational programme is supported by an Independent Educational Grant from Daiichi Sankyo.

Metastatic breast cancer: Understanding HER2-low and HER2-ultralow classification Video podcast

This educational programme is supported by an Independent Educational Grant from AstraZeneca 

Metastatic breast cancer: Understanding HER2-low and HER2-ultralow classification

Dr Komal Jhaveri

Dr Komal Jhaveri

Oncology Brothers (Moderators)

Oncology Brothers (Moderators)

Non-accredited Independent Medical Education BREAST CANCER CONNECT

This educational programme is supported by an Independent Educational Grant from AstraZeneca 

Update from ENETS 2026

Prof. Louis de Mestier

Prof. Louis de Mestier

Prof. Timon Vandamme

Prof. Timon Vandamme

Dr Alice  Durand

Dr Alice Durand

NET CONNECT Non-accredited Independent Medical Education

This educational programme is supported by an Independent Educational Grant from Ipsen. The content published on this website is under the responsibility of its authors. Some scientific data published on this website may not have been validated by the relevant Marketing Authorisation Committees and should not be put into practice. It should be read and understood with the utmost discernment and is provided for the purpose of disseminating information on the current state of research to the international scientific community.

Update from ENETS 2026 Conference update

This educational programme is supported by an Independent Educational Grant from Ipsen. The content published on this website is under the responsibility of its authors. Some scientific data published on this website may not have been validated by the relevant Marketing Authorisation Committees and should not be put into practice. It should be read and understood with the utmost discernment and is provided for the purpose of disseminating information on the current state of research to the international scientific community.

Personalised treatment in childhood cancer: A journey through <i>NTRK</i> fusion testing Patient Support
NTRKers ICAN international cancer advocacy network Biomarker Collaborative

This educational programme is supported by an Independent Educational Grant from Bayer.

Personalised treatment in childhood cancer: A journey through NTRK fusion testing

Linet Menachery

Linet Menachery

NTRKers ICAN international cancer advocacy network Biomarker Collaborative
Non-accredited Independent Medical Education PRECISION ONCOLOGY CONNECT

This educational programme is supported by an Independent Educational Grant from Bayer.

Shared decision-making for prostate cancer patients

Prof. Gunhild  von Amsberg

Prof. Gunhild von Amsberg

GU CONNECT Non-accredited Independent Medical Education
ZERO Urobel VZW | ASBL EAUN ICAN international cancer advocacy network

This educational programme is supported by an Independent Educational Grant from AstraZeneca 

Shared decision-making for prostate cancer patients Interactive Patient Case Video (IPCV)
ZERO Urobel VZW | ASBL EAUN ICAN international cancer advocacy network

This educational programme is supported by an Independent Educational Grant from AstraZeneca 

The evolving treatment landscape in <i>HER2</i>-mutant NSCLC Micro learning - Video, slides and more
ICAN international cancer advocacy network Biomarker Collaborative Exon20group

This educational programme is supported by an Independent Educational Grant from Bayer

The evolving treatment landscape in HER2-mutant NSCLC

Dr Devika  Das

Dr Devika Das

Dr Tom Newsom-Davis

Dr Tom Newsom-Davis

ICAN international cancer advocacy network Biomarker Collaborative Exon20group
Non-accredited Independent Medical Education LUNG CONNECT

This educational programme is supported by an Independent Educational Grant from Bayer

Select datopotamab deruxtecan-associated adverse events

Dr Aaron Lisberg

Dr Aaron Lisberg

LUNG CONNECT Non-accredited Independent Medical Education
Exon20group Biomarker Collaborative ICAN international cancer advocacy network Lung Cancer Europe

This educational programme is supported by an Independent Educational Grant from AstraZeneca.

Select datopotamab deruxtecan-associated adverse events Speed Read
Exon20group Biomarker Collaborative ICAN international cancer advocacy network Lung Cancer Europe

This educational programme is supported by an Independent Educational Grant from AstraZeneca.

Highlights from ASCO 2026 Conference update
ICAN international cancer advocacy network Digestive Cancers Europe

This educational programme is supported by COR2ED

GI and hepatobiliary cancer highlights from ASCO 2026

Prof. Hans Prenen

Prof. Hans Prenen

ICAN international cancer advocacy network Digestive Cancers Europe
Non-accredited Independent Medical Education

This educational programme is supported by COR2ED